BECLOMETASONE

DRUG5 trials

Sponsors

Sanofi-Aventis Research & Development, Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Sanofi-Aventis Recherche & Developpement, University of Dundee, Imperial College London

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseEpisodic expiratory wheezingRespiratory tract diseases - Wheezing

Phase 2

Preschool Wheeze: Inflammation/Infection Guided Management

CompletedNCT02517099

Imperial College LondonAsthma

Start: 2015-06-05End: 2018-08-17Updated: 2023-03-06

Phase 3

A randomized, double-blind, placebo-controlled, parallel group study to assess the efficacy and long-term safety of dupilumab in children 2 to <6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze

RecruitingCTIS2023-504331-41-00

Sanofi-Aventis Research & DevelopmentRespiratory tract diseases - Wheezing, Asthma

Start: 2024-08-02Target: 69Updated: 2025-07-17

Phase 4

Beta Blocker Therapy in Moderate to Severe COPD

CompletedNCT01656005

University of DundeeChronic Obstructive Pulmonary Disease

Start: 2012-08-31End: 2016-07-31Updated: 2019-04-23

Inhaled corticosteroids in young children with episodic wheezing: a multicenter cluster RCT

Not yet recruitingCTIS2025-522694-11-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Episodic expiratory wheezing

Target: 285Updated: 2025-10-09

AIRITY: A hybrid cross-sectional and prospective study to assess patient characteristics, disease burden, disease control, phenotypes, endotypes, and outcomes in a real-world setting in patients with asthma

Not yet recruitingCTIS2025-524916-13-00

Sanofi-Aventis Recherche & DeveloppementAsthma

Target: 346Updated: 2026-09-10

Related Papers

P277 Bisoprolol blunts domiciliary fev1 in copd patients taking concomitant dual or triple inhaler therapy

2017-11-15

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD

2017-09-011 citations

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD

QJM2017-07-2114 citations